Dolby Laboratories, Inc. (NYSE:DLB) Shares Could Be 37% Below Their Intrinsic Value Estimate
Rosenblatt Securities Maintains Dolby Laboratories(DLB.US) With Buy Rating, Raises Target Price to $100
Recent Dividend Declarations
Stocks Fall Ahead Of Nvidia Earnings, Dollar Resumes Gains, Bitcoin Reaches New Record Highs: What's Driving Markets Wednesday?
Barrington Maintains Dolby Laboratories(DLB.US) With Buy Rating, Maintains Target Price $100
Dolby Laboratories Is Maintained at Outperform by Barrington Research